Directed evolution of super-secreted variants from phage-displayed human Interleukin-2
出版年份 2019 全文链接
标题
Directed evolution of super-secreted variants from phage-displayed human Interleukin-2
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-28
DOI
10.1038/s41598-018-37280-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells
- (2018) Tania Carmenate et al. JOURNAL OF IMMUNOLOGY
- Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
- (2017) Rodrigo Vazquez-Lombardi et al. Nature Communications
- Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
- (2017) Christian Klein et al. OncoImmunology
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
- (2015) Suman Mitra et al. IMMUNITY
- Molecular dissection of the interactions of an antitumor interleukin-2-derived mutein on a phage display-based platform
- (2015) Gertrudis Rojas et al. JOURNAL OF MOLECULAR RECOGNITION
- Formulation and Stability of Cytokine Therapeutics
- (2015) Tiina Lipiäinen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A combinatorial mutagenesis approach for functional epitope mapping on phage-displayed target antigen
- (2014) Yanelys Cabrera Infante et al. mAbs
- High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
- (2013) Volker Jäger et al. BMC BIOTECHNOLOGY
- Aggregation Prone Regions and Gatekeeping Residues in Protein Sequences
- (2013) Jacinte Beerten et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
- (2013) Geok Choo Sim et al. JOURNAL OF CLINICAL INVESTIGATION
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- Fine epitope specificity of antibodies against interleukin-2 explains their paradoxical immunomodulatory effects
- (2013) Gertrudis Rojas et al. mAbs
- Protein synthesis rate is the predominant regulator of protein expression during differentiation
- (2013) A. R. Kristensen et al. Molecular Systems Biology
- Soluble expression of proteins correlates with a lack of positively-charged surface
- (2013) Pedro Chan et al. Scientific Reports
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Evolutionary selection for protein aggregation
- (2012) Natalia Sanchez de Groot et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Toward a Molecular Understanding of Protein Solubility: Increased Negative Surface Charge Correlates with Increased Solubility
- (2012) Ryan M. Kramer et al. BIOPHYSICAL JOURNAL
- Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: A versatile platform for fine epitope mapping
- (2012) Gertrudis Rojas et al. IMMUNOBIOLOGY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- General strategy for the generation of human antibody variable domains with increased aggregation resistance
- (2012) K. Dudgeon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insufficient (Sub-native) Helix Content in Soluble/Solid Aggregates of Recombinant and Engineered Forms of IL-2 Throws Light on How Aggregated IL-2 is Biologically Active
- (2012) Uzma Fatima et al. PROTEIN JOURNAL
- Cellular Strategies for Regulating Functional and Nonfunctional Protein Aggregation
- (2012) Jörg Gsponer et al. Cell Reports
- A Low-Toxicity IL-2-Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity
- (2011) S. D. Gillies et al. CLINICAL CANCER RESEARCH
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein Thermostability Calculations Using Alchemical Free Energy Simulations
- (2010) Daniel Seeliger et al. BIOPHYSICAL JOURNAL
- Evolution of interleukin-15 for higher E. coli expression and solubility
- (2010) G. Behar et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells
- (2009) David V. Liu et al. JOURNAL OF IMMUNOTHERAPY
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
- (2008) Berk Hess et al. Journal of Chemical Theory and Computation
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started